DemDx is an award-winning AI healthcare company based in London, founded in 2015. Their CE certified clinical reasoning platform, developed in consultation with over 200 medical experts, enables frontline practitioners to confidently assess, identify necessary tests, and present recommendations for further care before the patient sees a doctor. The DemDx platform is 22% more accurate than Harvard-trained junior doctors, delivers 85% accuracy at first assessment, and reduces time to assess by 40%. The latest Venture Round investment on 22 May 2023 was led by Angel Academe. The company operates in the Education and Health Care industries, striving to revolutionize frontline healthcare delivery with the slogan: "Frontline healthcare delivery. Better. Safer. Faster."
No recent news or press coverage available for DemDx.